Both in Pharmaceuticals
ANI Pharmaceuticals vs Nurix Therapeutics
Over the past year ANIP returned −23.3% and NRIX returned +26.1%; their daily moves had a correlation of 0.08.
ANIP −23.3% NRIX +26.1%Growth of $1, one year, split-adjusted
| Metric | ANIP | NRIX |
|---|---|---|
| Price | $72.16 | $15.92 |
| Market cap | $1.66B | $1.74B |
| Today | −0.17% | −38.34% |
| 1 month | +0.9% | −29.6% |
| 6 months | −14.2% | −5.7% |
| Year to date | −8.6% | −16.1% |
| 1 year | −23.3% | +26.1% |
| Revenue growth (YoY) | +25.9% | +8426.3% |
| Gross margin | 62.4% | 100.0% |
| Net margin | 8.6% | 81.7% |
| P/E (TTM) | 16.6× | 5.9× |
| Price / sales | 1.7× | 2.5× |
| Net cash | -$234.7M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 26.7% | 105.0% |
| Short % of float | 18.1% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).